Structured Summary
Abstract
A recombinant granulocyte colony-stimulating factor that is used to treat or prevent NEUTROPENIA in patients receiving myelosuppressive cancer chemotherapy, for the preparation and collection of blood progenitor cells in PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; and in the treatment of severe congenital neutropenia. Component 1 and Component 2 differ by absence or presence of Neu5Ac in 2-6 linkage to GalNAc side chain.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
Drug Class
Pharmacological Action
MeSH Record
Synonyms
4 entry terms
- Euprotin
- Granocyte
- Lenograstim, Component 1
- Lenograstim, Component 2
MeSH Record
Aspects Covered
26 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, analogs & derivatives, analysis, biosynthesis, cerebrospinal fluid, chemical synthesis, chemistry, classification, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, ultrastructure, urine.
MeSH Record
History Note
2019 (1993)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Lenograstim. Medical Subject Headings (MeSH). 2026. Unique ID D000078224. http://id.nlm.nih.gov/mesh/2026/D000078224
- Lenograstim. In: Wikipedia. https://en.wikipedia.org/wiki/Lenograstim
- Lenograstim. In: Wikidata. https://www.wikidata.org/wiki/Q6523037